Looking for a trusted source of pharmaceutical-grade bacteriostatic water
Immediate medical review is necessary for these signs, and therapy should be paused until a clinician evaluates the cause
(2024, February 6)
However, like all research peptides, it must be used only in non-human laboratory settings , and should never be promoted or interpreted as a therapeutic product
Lip 2 , Ching Hui Sia 1 , Benjamin Tan 1 1 National University of Singapore, Singapore, Singapore, 2 University of Liverpool, Liverpool, United Kingdom Background and Aims: The differential impact of atrial fibrillation detected after stroke (AFDAS) compared to known atrial fibrillation (kAF) on outcomes following thrombolysis with intravenous recombinant tissue plasminogen activator (rtPA) in ischemic stroke patients remains unclear.We aimed to evaluate the effect of AF status no AF, kAF, or AFDAS on functional and survival outcomes in ischemic stroke patients treated with thrombolysis
safety and tolerability Key Results Weight Reduction Mean percentage change in weight at week 48: 1 mg: 8.7% 4 mg: 17.1% 8 mg: 22.8% 12 mg: 24.2% Placebo: 2.1% 100% of participants on 8 mg and 12 mg achieved 5% reduction
